Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Finished Goods (2019 - 2025)

Historic Finished Goods for Xtant Medical Holdings (XTNT) over the last 10 years, with Q3 2025 value amounting to $30.6 million.

  • Xtant Medical Holdings' Finished Goods fell 412.62% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year decrease of 412.62%. This contributed to the annual value of $29.2 million for FY2024, which is 408.5% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Finished Goods stood at $30.6 million for Q3 2025, which was down 412.62% from $31.2 million recorded in Q2 2025.
  • Xtant Medical Holdings' Finished Goods' 5-year high stood at $31.9 million during Q3 2024, with a 5-year trough of $10.6 million in Q2 2022.
  • In the last 5 years, Xtant Medical Holdings' Finished Goods had a median value of $16.3 million in 2021 and averaged $20.7 million.
  • Its Finished Goods has fluctuated over the past 5 years, first plummeted by 3146.4% in 2022, then surged by 15862.49% in 2024.
  • Over the past 5 years, Xtant Medical Holdings' Finished Goods (Quarter) stood at $11.8 million in 2021, then decreased by 7.67% to $10.9 million in 2022, then surged by 158.35% to $28.1 million in 2023, then rose by 4.08% to $29.2 million in 2024, then grew by 4.72% to $30.6 million in 2025.
  • Its last three reported values are $30.6 million in Q3 2025, $31.2 million for Q2 2025, and $30.5 million during Q1 2025.